desloratadine has been researched along with Lung Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, W; Huang, L; Huang, Y; Liu, J; Ma, W; Ma, Y; Wu, X; Yang, Y; Zhang, L; Zhang, Y; Zhao, H; Zhou, H; Zhou, T | 1 |
1 trial(s) available for desloratadine and Lung Neoplasms
| Article | Year |
|---|---|
Comparison of aprepitant versus desloratadine for EGFR-TKI-induced pruritus: A randomized phase 2 clinical trial.
Topics: Aged; Aprepitant; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Humans; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Pruritus; Quality of Life | 2022 |